Brooke Story

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Sarah K. Mohr, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brooke Story:

Company Role Class Num Shares Value Price $ Report Date Ownership
LivaNova PLC Director Ordinary Shares 6,232 $336,154 $53.94 18 Nov 2025 Direct
LivaNova PLC Director Restricted Stock Units 4,042 $187,231 $54.81 15 Jun 2025 Direct
Sigilon Therapeutics, Inc. Director Stock Option (Right to Buy) 8,888 $6,666 $0.7500 26 May 2022 Direct

Insider Reports Filed by Brooke Story

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LIVN LivaNova PLC 18 Nov 2025 1 -$13,485 4 Director 19 Nov 2025, 15:57
LIVN LivaNova PLC 15 Jun 2025 4 -$18,762 4 Director 17 Jun 2025, 16:54
LIVN LivaNova PLC 15 Jun 2024 4 -$30,765 4 Director 18 Jun 2024, 16:05
LIVN LivaNova PLC 15 Sep 2023 3 -$19,941 4 Director 19 Sep 2023, 17:08
LIVN LivaNova PLC 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 15:35
LIVN LivaNova PLC 15 Sep 2022 0 $0 3 Director 19 Sep 2022, 16:59
LIVN LivaNova PLC 15 Sep 2022 1 $0 4 Director 19 Sep 2022, 16:56
/report/000141588922005825-story-brooke-2022-05-26 Sigilon Therapeutics, Inc. 26 May 2022 1 $0 4 Director 27 May 2022, 17:00
/report/000141588921003033-story-brooke-2021-06-14 Sigilon Therapeutics, Inc. 14 Jun 2021 1 $0 4 Director 16 Jun 2021, 16:10
/report/000141588921003032-story-brooke-2021-06-14 Sigilon Therapeutics, Inc. 14 Jun 2021 0 $0 3 Director 16 Jun 2021, 16:05